Table 6 Health-related data for included studies
Author (Year) | Health Outcomes | Follow up frequency and extent of Health outcomes | Patient sample loss to follow up | Effectiveness Measure (Instrument) | Preference-based Outcome |
|---|---|---|---|---|---|
Levin et al. (1991) [13] | Total cost during study period (cost-benefit analysis) | NR | 82/147 (56%) of patients completed initial 3-months. 78/147 (53%) of patients completed year-1. 72/147 (49%) of patients completed year-2. Note: figures given of CRPP arm | Total cost per patient | Not a preference-based outcome |
Oldridge et al. (1993) [4] | HRQL | Baseline, 4, 8 and 12-months | NR | QALY (NR) | Time-trade off change score |
Ades et al. (1997) [16] | Survival | N/A | N/A | Year of life saved | Not a preference-based outcome |
Carlson et al. (2000) [18] | Cardiovascular health | Baseline and 6-months | At 6-months, 67/80 (84%) | Primary: maximal oxygen consumption, low-density lipoprotein cholesterol | Not a preference-based outcome |
Hall et al. (2002) [15] | HRQL | Every week for 6-weeks, then 3, 6 and 12-months. | 13 (9%) patients did not complete any questionnaires (adjusted sample size, n = 129) At 3-months, 98/129 (76%) patient data At 6-months, 101/129 (78%) patient data At 12-months, 76/129 (59%) patient data | Return to normal activities and Quality of Life score (Health Measurement Questionnaire) | Not a preference-based outcome |
Southard et al. (2003) [9] | Monetary equivalent for (costs of) cardiovascular events | Baseline and 6-months | At 6-months, 100 (96%) patient data | Health care costs | Not a preference-based outcome |
Yu et al. (2004) [19] | HRQL | Phase 1 (baseline), phase 2, 3 and 4 (2-years) | At 2-yrs., data available for 204 (76%) patients. | QALY (SF-36) | Patient reported time trade off score |
Briffa et al. (2005) [12] | HRQL | Baseline, 6 and 12-months | At 6-months, 109/113 (96%) patient data At 12-months, 105/111 (95%) patient data | QALY (SF-36 and UBQ-H) | Preference-based utility based on UBQ-H questionnaire |
Reid et al. (2005) [17] | Exercise, cardiac risk, HRQL, depression | Baseline, 3, 12 and 24-months | At 3-months, 344 (87.8%) patient data At 12-months, 314 (80.1%) patient data At 24-months, 252 (64.2%) patient data | Peak oxygen uptake, kilojoules of energy related to activity, HDL-C and TGs, cardiac events, Heart diseases HRQL (McNew instrument), generic HRQL (SF-36), Depressive symptoms (Centre for Epidemiological Studies Depression scale) | Not a preference-based outcome |
Jolly et al. (2007) [11] | HRQL | 6,12 and 24-months | At 6-months, 485 (93%) patient data At 12-months, 475 (91.5%) patient data At 24-months, 461 (89%) patient data | QALY (EQ-5D) | EQ-5D summary score based on UK value set tariff |
Taylor et al. (2007) [10] | HRQL | Baseline, 3 and 9-months | At 9-months, data available for 48 (80%) and 32 (73%) of the home- and hospital-based groups respectively. | QALY (EQ-5D) | EQ-5D summary score based on UK value set tariff |
Dendale et al. (2008) [14] | Monetary equivalent for (costs of) cardiovascular events | Two examinations in 6-month period, single examination annually thereafter | NR | Health care costs | Not a preference-based outcome |
Huang et al. (2008) [21] | Survival | N/A | N/A | Year of life saved | Not a preference-based outcome |
Papadakis et al. (2007) [2] | HRQL | 3, 6, 12, 15 and 24-months. | At 2-yrs., data available for 307 (78%) patients. | QALY (NR) | Time trade off preference-based utility scores |
Spronk et al. (2008) [20] | HRQL | N/A | N/A | QALY | Time-trade off preference-based utility score |